Skip to main content

Form 8.3 – [GLOBALDATA PLC – 23 05 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GLOBALDATA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects

SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”) is a leading provider of games and entertainment and the indirect parent company of Epicsoft Asia Pte. Ltd. (the “Offeror”), the bidder seeking to acquire all of the issued and paid-up ordinary shares in the capital of Ban Leong Technologies Limited (SGX: B26) (“Ban Leong”), excluding shares held in treasury (the “Shares”) pursuant to Rule 15 of the Singapore Code on Take-overs and Mergers (the “Offer”). The Offeror today announced that the total number of Shares owned, controlled or agreed to be acquired by the Offeror and parties acting in concert with it (including by way of valid acceptances of the Offer) represent approximately 50.90% of the total number of Shares as of May 27, 2025, and accordingly, the Offer has become...

Continue reading

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced XOMA Royalty has purchased the future mezagitamab (TAK-079) royalty and milestone interests held by BioInvent for USD $20 million at closing, with a total transaction of up to USD $30 million. “This transaction further builds the potential of XOMA Royalty’s late-stage royalty portfolio by increasing our economics in a promising Phase 3 program already in our portfolio,” stated Brad Sitko, Chief Investment Officer of XOMA Royalty.  “We appreciate the longstanding relationship...

Continue reading

Check Point to Acquire Veriti to Transform Threat Exposure Management and Reduce Organizations’ Cyber Attack Surface

Veriti is the first to introduce preemptive exposure management delivering automated remediation of threat exposure risks and collaborative threat prevention across complex multi-vendor environments REDWOOD CITY, Calif., May 27, 2025 (GLOBE NEWSWIRE) — AI-fueled attacks and hyperconnected IT environments have made threat exposure one of the most urgent cybersecurity challenges facing enterprises today. In response, Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader of cyber security solutions, today announced a definitive agreement to acquire Veriti Cybersecurity, the first fully automated, multi-vendor pre-emptive threat exposure and mitigation platform. “The acquisition of Veriti marks a significant step toward realizing our hybrid mesh security vision,” said Nadav Zafrir, CEO at Check Point Software...

Continue reading

Results Announcement

27 May 2025. The Republic of Iceland (the “Offeror“) announces today the results of its invitation to holders of its €500,000,000 0.625 per cent. Notes due 3 June 2026 (ISIN: XS2182399274) (of which €500,000,000 in aggregate nominal amount is outstanding as at the date hereof) (the “Notes“) to tender their Notes for purchase by the Offeror for cash (such invitation, the “Offer“). The Offer was announced on 19 May 2025 and was made on the terms and subject to the conditions contained in the tender offer memorandum dated 19 May 2025 (the “Tender Offer Memorandum“) prepared by the Offeror in connection with the Offer. Capitalised terms used in this announcement but not defined have the meaning given to them in the Tender Offer Memorandum. The Expiration Deadline for the Offer was 5.00 p.m....

Continue reading

Diginex Signs MOU to Acquire Matter DK ApS, Expanding Its Sustainability Data and AI Capabilities

LONDON, May 27, 2025 (GLOBE NEWSWIRE) — Diginex Limited (“Diginex”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced the signing of a Memorandum of Understanding (MOU) dated 23 May 2025 for an all-share acquisition of Matter DK ApS (“Matter”), an innovative ESG data company focused on delivering sustainability data and analytics solutions to the investment industry and helping financial institutions understand and communicate the sustainability of investments. Matter is based in Copenhagen, Denmark, and their largest shareholder is NASDAQ, followed by the founding management team who will remain with the business following the closing of the acquisition pursuant to multi-year employment agreements. The MOU values the equity of Matter at $13 million which will be paid through the issuance of...

Continue reading

Wereldhave announces first joint venture, with Sofidy (Tikehau Group), acquiring shopping center Stadshart Zoetermeer in the Netherlands

Wereldhave and Sofidy (Tikehau Group), a leading European real estate investment and asset management firm, have partnered on the acquisition of shopping center Stadshart Zoetermeer, and parking garages, in Zoetermeer, the Netherlands, from Unibail-Rodamco-Westfield. The asset has a total gross lettable area of approximately 59,000 m² (excluding parking). This acquisition marks Wereldhave’s first joint venture and aligns fully with the company’s strategy and acquisition criteria. Wereldhave will act as asset, property and leasing manager with the view to enhance the value for all stakeholders through its proficient Dutch asset management platform and by implementing its LifeCentral strategy. The total purchase price amounts to € 150m (€ 165.6m including transaction taxes) with Wereldhave investing a 15% equity stake. The joint venture...

Continue reading

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

NYC, May 24, 2025 (GLOBE NEWSWIRE) — NEW YORK, May 24, 2025 / GlobeNewswire/ — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Star Equity Holdings, Inc. (NASDAQ: STRR), relating to the proposed Merger with Hudson Globl, Inc. that will create NewCo. Upon completion of the Merger, Hudson shareholders will own approximately 79% of NewCo, and Star shareholders will own approximately 21% of NewCo’s estimated 3.49 million shares outstanding. Pending regulatory and shareholder approvals, the proposed Merger is anticipated to close in...

Continue reading

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

NYC, May 24, 2025 (GLOBE NEWSWIRE) — NEW YORK, May 24, 2025 / GlobeNewswire/ — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Vigil Neuroscience, Inc. (NASDAQ: VIGL), relating to the proposed merger with French company, Sanofi. Under the terms of the agreement, Sanofi will acquire Vigil for an upfront payment of $8.00 per share of common stock in cash. Vigil shareholders will also receive a non-tradeable contingent value right entitling the holder to potentially receive an additional $2.00 per share in cash payable following the...

Continue reading

BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.

Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company, today announced it has signed a definitive share exchange agreement with Streamex Exchange Corporation (“Streamex”), a privately held company specializing in the tokenization of real-world assets, with a focus on bringing commodities on-chain. The signing of the definitive agreement represents a major milestone for both Streamex and BioSig, propelling the business combination forward, and fast-tracking the growth of Streamex’s tokenization business. During this transaction, Streamex has made significant progress with some very exciting developments expected to be shared in the coming weeks.  Key Highlights of the Transaction:Streamex...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.